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axillofacial departments in 23 surgical units in Italy have been increasingly involved in facing the COVID-19 emergency. Elective surgeries
ave been progressively postponed to free up beds and offer human and material resources to those infected. We compiled an inventory of
2 questions to evaluate the impact of the SARS-COV2 epidemic on maxillofacial surgery in 23 selected Italian maxillofacial departments.
he questionnaire focused on three different aspects: the variation of the workload, showing both a reduction of the number of team members
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-16% among specialists, -11% among residents) due to reallocation or contamination and a consistent reduction of elective activities (the
umber of outpatient visits cancelled during the first month of the COVID-19 epidemic was about 10 000 all over Italy), while only tumour
urgery and trauma surgery has been widely guaranteed; the screening procedures on patients and physicians (22% of maxillofacial units
ound infected surgeons, which is 4% of all maxillofacial surgeons); and the availability of Personal Protective Equipment, is only considered
o be partial in 48% of Maxillofacial departments.
his emergency has forced those of us in the Italian health system to change the way we work, but only time will prove if these changes have
een effective.
 2020 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
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he alleged first case of COVID-19 in Italy was diagnosed
n 20 February 2020 in the town of Codogno, Lombardy.
Despite the attempt to limit the outbreak to the defined
red zone”, by quarantining all citizens and denying entry or
eparture from the area, similar cases were diagnosed in other
ities without evident epidemiological correlation, starting
he day after the first identification.
During the last week of February, the prevalence of Covid-
9 started to rise not only in Italy but, with a delayed but
imilarly increasing trend, also in the rest of Europe. As we
re writing, the cumulative incidence is of more than 80 000
ases of COVID19 in Italy. Nevertheless, because of a series
f unclear factors, northern Italy (in particular Lombardy,
eneto, and the Emilia Romagna regions) suffered a heavier
ealthcare and, tragically, death burden.
Although general practitioners, emergency departments,
nfectious diseases units, respiratory disease units, and inten-
ive care units (ICUs) were and still are standing in the font
ine of the action, every department of every hospital all
ver Italy was increasingly involved in facing this unique
nd unprecedented health emergency.1 Since maxillofacial
urgery departments are not standing in the front line of this
truggle, elective surgeries have been postponed to free up
eds and offer human and material resources and day-to-day
are has been revolutionised in order to respond to the rapidly
volving health emergency.2
This article, involving 23 maxillofacial surgery depart-
ents from northern to southern Italy, focuses on the first
our weeks of this pandemic, aiming to describe both the
eatures of and obstacles to their involvement.
aterial  and  methods
e compiled an inventory of 32 questions to evaluate the
mpact of SARS-COV2 epidemic on maxillofacial surgeryPlease cite this article in press as: Allevi F, et al. Impact of COVID-19
Surg  (2020), https://doi.org/10.1016/j.bjoms.2020.04.035
n 23 selected Italian maxillofacial departments, which were
hosen to represent the present situation across the coun-
ry, with an emphasis on the role of teaching departments
1
s
thenever possible. Each department designated a special-
st from the staff to answer the questionnaire. Answers were
ubsequently collected anonymously, keeping track of the
ocation of the department in order to geographically corre-
ate answers.
The questionnaire (see Supplemental Material) was built
round three major aspects:
02" Changes in the workload in terms of outpatient clinic,
day-surgery and general anaesthesia surgery;
02" Screening COVID-19 procedures used for patients
and/or healthcare workers;
02" Workforce and patient protection methods to avoid
SARS-COV2 spreading during daily activities.
Moreover, personal protective equipment (PPE) supply
as considered to be a relevant topic in our field, due to
he high frequency of oral and nasal cavity explorations.
Quantitative and qualitative data were recorded and statis-
ically analysed using Excel software 15.0 (Microsoft Corp).
ur analysis divided Italian maxillofacial units into 3 areas:
igh SARS-COV2 diffusion area (“red zone” including Lom-
ardy, Emilia-Romagna and Veneto regions), intermediate
ARS-COV2 diffusion area (“yellow zone” including Pied-
ont and Liguria regions) and low SARS-COV2 diffusion
rea (“green zone” including the remaining Italian regions).
esults
e observed a reduction in the number of team members
or all the considered zones, mostly among maxillofacial
pecialists (16% reduction vs. 11% reduction for residents)
Table 1].
Some maxillofacial surgeons, mostly in the red and yellow
reas, had positive SARS-COV2 naso-pharyngeal swabs (4%
f all maxillofacial specialists and residents in 22% of all
axillofacial departments assessed) and were isolated for epidemic on maxillofacial surgery in Italy. Br  J  Oral  Maxillofac
4 days in the so-called “standard quarantine”, waiting for
ymptoms’ remission or negative test results in order to return
o work [Table 2].
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Table 1
Maxillofacial surgeons number variation during COVID-19 epidemic. Data are mean (SD)
Number of specialists Number of residents
Pre-epidemic In-epidemic Variation rate Pre-epidemic In-epidemic Variation rate
Red zone 7.2 (1.99) 5.90 (2,33) -18% 4.5 (2.91) 4.2 (2.93) -6%
Yellow zone 8.50 (0.71) 4.50 (6,36) -47% 7.00 (9.89) 7.00 (9.89) 0%
Green zone 7.27 (2.20) 6.73 (2,41) -6% 4.18 (6.06) 3.36 (5.50) -20%
23 Maxillofacial Units 7.35 (1,99) 6,17 (2,67) -16% 4,56 (5,02) 4,04 (4,77) -11%
Table 2
Positive doctors’ percentage and their management.
Positive doctors
Yes, there are positive doctors in my department No, there are not
positive doctors in my
department
I don’t know if there are
positive doctors in my
department
Standard quarantine Prolonged quarantine Come back work
Red zone 3% 0% 0% 36% 4%
Yellow zone 0.5% 0% 0% 11% 0%
Green zone 0.5% 0% 0% 40% 5%
23 Maxillofacial Units 4% 0% 0% 87% 9%
Table 3
Maxillofacial surgeon re-allocation during COVID-19 epidemic.
Re-allocated doctors Wards for re-allocation
COVID
internal
medicine
NON-COVID
internal
medicine
Infectious
disease
Respiratory
disease
ER ICU Service
medicine
Other
Red zone 3.60 out of 117 44% 0% 6% 6% 6% 0% 6% 0%
Yellow zone 0 out of 31 0% 0% 0% 0% 0% 0% 0% 0%
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Creen zone 1.00 out of 126 6% 0% 
3 Maxillofacial Units 2.04 out of 274 50% 0% 
Among the causes of staff reduction there was also the
ull-time or part-time re-allocation of maxillofacial surgeons,
oth specialists and residents (17% of team members). The
ajority went to COVID internal medicine units (50% of
he reallocated resources), while 19% of physicians were
ncluded in emergency departments, 13% in the service
edicine units, 6% in the infectious disease units and 6%
n the respiratory disease units. The re-allocation process of
axillofacial surgeons took part mostly in red and yellow
ones [Table 3].
Questionnaire results show an important decrease in
very maxillofacial activity, with no substantial difference
mong the three identified zones. Outpatient visits showed
n 87% decrease, while outpatient surgery (i.e. day surgery)
ecreased by 86% [Table 4]. The maintained activity includes
iopsy and skin cancer surgery in all the departments.
Inpatient general anaesthesia surgery reduced as well,
78% countrywide reduction. Despite COVID-19 epidemic,
ost of maxillofacial surgery units have carried on the sur-
ical management of facial trauma - although with a much
educed incidence (74%) and head and neck oncology (90%),Please cite this article in press as: Allevi F, et al. Impact of COVID-19 
Surg  (2020), https://doi.org/10.1016/j.bjoms.2020.04.035
onsidered time-dependent diseases. On the other hand, only
ew departments have maintained other kind of surgery, such
f
h
50% 0% 13% 0% 6% 6%
6% 6% 19% 0% 13% 6%
s craniofacial (9%), microsurgery (17%) and paediatric
urgery (4%).
The number of visits performed weekly among the 23
axillofacial surgical units over Italy in the pre-epidemic
eriod was about 2518. Therefore, during the first Covid-19
pidemic month, the missed maxillofacial visits were about
0 000. Similar considerations could be referred to outpatient
urgery, with the unavoidable delay of over 1 700 procedures,
s well as 800 missed inpatient maxillofacial surgeries during
arch 2020over the 23 departments.
Speaking about private practice, only 9% of maxillofa-
ial units maintained their current activity, mainly about
ndelayable procedures such as oncological evaluations and
urgery.
A total of 61% of maxillofacial surgery have been merged
ith other units, while 17% remained open with a reduced
umber of beds. A total of 9% of maxillofacial wards, mainly
n the red zone, have been converted into COVID-19 units.
A total of 43% of questionnaires (10 out of 23) reported
hat regional healthcare systems identified a number of
OVID-19-free hospitals (hubs) to warrant contamination-epidemic on maxillofacial surgery in Italy. Br  J  Oral  Maxillofac
ree essential surgical procedures. The designated hub
ospitals dealt with pathologies that could not be postponed:
0% of hub hospitals dealt with major traumas, 50% dealt
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Table 4
Visits and Surgery variation during COVID-19 epidemic. Data are mean (SD)
Outpatient visits per week Outpatient surgery per week Inpatient surgery per week
Pre-epidemic In-epidemic Variation
rate
Pre-epidemic In-epidemic Variation
rate
Pre-epidemic In-epidemic Variation
rate
Red zone 140.5 (68.97) 1.,5 (±12,92) -87% 25.1 (21,06) 4.1 (7,21) -84% 11.66 (3,06) 2.55 (0,97) -78%
Yellow zone 110.00 (14.14) 12.5 (±17,67) -89% 22.50 (10,61) 2.00 (2,82) -91% 8.50 (0,71) 2.01 (2,82) -76%
Green zone 114.36 (82.98) 14.09 (±8,17) -88% 19.72 (14,19) 2.27 (1,84) -88% 12.54 (8,74) 2.81 (1,60) -78%
23 Maxillofacial Units 125.34 (72,60) 15,86 (10,89) -87% 22,30 (16,88) 3,04 (4,91) -86% 11,81 (6,31) 2,63 (1,40) -78%
Table 5
Screening procedures on patients during COVID-19 epidemic.
Nasopharyngeal swab
Yes, for
everyone
Yes, hospitalised
patients
Yes, patients
undergoing
surgery
Yes, patients
with
comorbidity
Yes,
symptomatic
patients
No
Red zone 0% 9% 9% 0% 9% 17%
Yellow zone 0% 0% 0% 0% 9% 0%
Green zone 0% 9% 0% 
23 Maxillofacial Units 0% 18% 9% 
Table 6
Positive patients’ percentage and their management.
Positive patients
yes no
isolated transferred
Red zone 0% 26% 17%
Yellow zone 0% 9% 0%
Green zone 0% 9% 39%
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utaly 0% 44% 56%
ith COVID-free traumas, 40% with COVID traumas, while
ajor head and neck oncology with postoperative ICU admis-
ion was performed in 70% of hub hospitals and COVID-free
ead and neck oncology in 50% of hub hospitals. Only three
tructures have been chosen as hub structures for paediatric
urgery (20%) and neurosurgery (10%), respectively.
Nasopharyngeal swabs were performed mostly in symp-
omatic patients (43%), followed by already hospitalised
atients (18%) and candidates for surgery (9%). This last
ate is low due to the recent introduction of such preoper-
tive screenings in most centres. 43% of patients screened
ositive for SARS-COV2 infection. These patients were
ransferred in Covid-19 departments for evaluation and treat-
ent [Table 5 and 6].
Speaking about PPE, FFP2/N95 masks were provided
n 61% of maxillofacial departments, mainly in the “red
one” (80%); a similar but reduced distribution was observed
onsidering FFP3/N99 masks, provided only in 26% of max-
llofacial units (40% red zones unit).
Disposable gloves and surgical masks were provided in
1% and in 100% of maxillofacial wards, respectively, whilePlease cite this article in press as: Allevi F, et al. Impact of COVID-19
Surg  (2020), https://doi.org/10.1016/j.bjoms.2020.04.035
isposable gowns were supplied only in 39% of maxillofacial
nits. PPE supply is considered to have been partial in 48% of
axillofacial departments, mainly in red (60%) and yellow
a
h0% 25% 13%
0% 43% 30%
100%) areas, while 48% of the remaining ones considered
he supply adequate for the requests, mostly in the green zone
73%).
Several methods have been applied to reduce SARS-
OV2 diffusion. During visits the most used methods were
imitation of social physical interaction (91%), health work-
rs wearing PPE (83%) and waiting room redesign (83%),
ollowed by using risk factor surveys (39%), telephone symp-
oms’ evaluation (35%) and patients PPE given out by the
ospital (35%).
During inpatient activity, similar methods are adopted.
he most used were again limitation of physical interaction
91%), limitation of relatives’ visits (96%), health workers
earing PPE (83%) and body temperature control of both
atients (61%) and health workers (48%). We assessed fewer
creening procedures such as nasopharyngeal swabs (26%),
elephone evaluations of CCOVID-19 symptoms (43%) and
isk factor surveys (52%).
iscussion
ince the COVID-19 epidemic started, maxillofacial elective
urgery was gradually reduced nationwide and clinical work
caled down in order to keep services running without putting
oth the healthcare workers and patients at risk.
A common trend emerged in keeping services running,
hile progressively reducing the outpatient access to those
olicited by primary care physicians and other specialists. For
utpatient visits, this kind of selection could be performed by
he identification of prescriptions marked as urgent or non-
rgent. epidemic on maxillofacial surgery in Italy. Br  J  Oral  Maxillofac
For what concerns outpatient and inpatient surgery, on
 clinical and management level, maxillofacial surgeons
ave to make important choices to identify cases that would
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gF. Allevi et al. / British Journal of Oral 
ecessarily need surgical treatment even in health emer-
ency situations. These choices are intended to guarantee
he ideal timing to perform surgery for time-dependent
athologies such as head and neck cancers and facial
rauma. Due to the emergent situation, guide-lines for Italian
axillofacial surgeons were not available, and other soci-
ties’ recent suggestions are not founded on evidence-based
edicine.3,4
Treatment of cleft lip and palate deformities were not
elayed over 9 months of age to avoid subsequent impair-
ent of speech. Also, patients with facial paralysis have been
dded to the list of urgent surgeries if the onset of paralysis
as close to 18 months in order to avoid losing the chance to
eanimate mimetic musculature.5
Even if some regional specific hubs have been identified
o collect all patients affected by a specific pathology in a
OVID-19-free location, allowing them to not suspend all
he elective surgery, the questionnaire focuses the attention on
he missed visits and surgical procedures since the COVID-
9 epidemic started. The huge reduction of outpatient visits
-87%) and outpatient (-86%) and inpatient surgical proce-
ures (-78%) that the questionnaire shows four weeks after
he beginning of the pandemic suggests a longer and longer
aiting lists for all non-urgent pathologies.
Four weeks after the pandemic started, at a time when
obody is able to say how long it will last, physicians are
tarting to wonder how the waiting list issue will be managed
t the end of the course of this pandemic. This already evident,
nd more and more emerging, problem should be managed
n order to guarantee an acceptable care level in terms of the
orrect timing of diagnosis and treatment.
Physicians can only assume that possible solutions to this
ssue include the permanent hiring of temporary workers and
he purchase of the medical and surgical tools, to increase the
orkforce and consequently the provided services.
The questionnaire answers show how a pandemic affects
rivate practice also. In order to protect both the healthcare
orkers and the patients, private practice has been interrupted
lmost everywhere. The exceptions are two wards in the
green zone” in which private practice is still possible for
rgent cases.
The temporary interruption of the private practice and the
longation of the waiting might increase the use of private
ractice in the future. On the contrary, a possible economic
risis might reduce private practice.
While the COVID-19 emergency was becoming more
nd more diffused and routine maxillofacial surgery activ-
ty reducing, a varyingnumber of maxillofacial staff needed
o be reallocated.
Maxillofacial surgeons and residents have mostly joined
OVID-19 internal medicine and emergency departments,
nd have provided temporary tracheostomies to patients and
asopharyngeal tests for health-workers and patients. FewPlease cite this article in press as: Allevi F, et al. Impact of COVID-19 
Surg  (2020), https://doi.org/10.1016/j.bjoms.2020.04.035
esources were allocated for shifts in respiratory and infec-
ious disease departments, due to the relevant skills required
n these wards. Other activities involved maxillofacial resi-
q
hxillofacial Surgery xxx (2020) xxx–xxx 5
ents in volunteering in full emergency medical services (999
quivalent).6
Eventually, personal safety in healthcare workers, both
n maxillofacial surgery practice and in new COVID-19
epartments, became a hot topic due to the high transmis-
ion rates of SARS-COV2. In fact, we frequently perform
erosol-generating procedures. This underlines the impor-
ance of wearing adequate personal protective equipment
PE during most of our shifts, balancing the lack of sup-
lies in this current emergency. Also, it seems reasonable
o avoid aerosol-generating procedures as much as possi-
le.
However, the availability of PPE replacements canvary
etween hospitals in different areas of Italy, as well between
ifferent wards in the same hospital. According to Xu et al,
he recommendation, in a COVID-19 endemic area, is that
hen dealing with patients with or without fever, practition-
rs should wear Level 2 protection gear (N95/FFP2 masks
r superior, medical protective glasses, disposable gown,
loves, medical hat, and boot covers).7
Level 2 protection protocols should be followed even dur-
ng our regular nose and throat visits. On the other hand,
isposable surgical masks should be used by patients as well
o reduce one-way diffusion. 7–9
For presumed and confirmed COVID-19 patients, surgery
ight be performed with Level 3 protection (in addition to
evel 2 protection, medical comprehensive respirator, medical
reathing mask or positive pressure headgear are required):
his material has not been utilised by surgeons of this survey
ecause it was not available. Several adjunctive second pro-
ection were taken in those cases: double protection for eyes
ndfeet, double gloves, neck protection, and an impermeable
own.
Nevertheless, we had to face the lack of PPE and proto-
ols during this first month of Covid-19 spreading. Even our
ame old disposable surgical masks became a good staple
n these days, while “true” PPE, such as FFP2/N95 masks
tarted being disseminated only in the last week. Only 61%
f maxillofacial departments has FFP2/N95 masks for sur-
ical activities, mostly in red zone areas (80%). Disposable
owns and FFP3/N99 masks are provided less often, while
isposable gloves, glasses, and surgical masks are adequately
upplied.
Similar considerations could be extended to other
ehavioural methods used to limit SARS-COV2 diffusion
oth during inpatient and outpatient practice, and applied
o healthcare workers and patients. Alongside personal
rotective equipment, the most required actions were the
emoval of unnecessary physical contacts, limited access
o the hospital/department for relatives, and body temper-
ture assessment before admission into the hospital for
atients. On the contrary and unfortunately, nasopharyn-
eal test for SARS-COV2 infection and risk factor screeningepidemic on maxillofacial surgery in Italy. Br  J  Oral  Maxillofac
uestionnaire were performed less often in different Italian
ospitals.
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onclusion
talian maxillofacial surgeons had an attitude of high collabo-
ation with non-surgical colleagues and 22% of maxillofacial
nits found infected surgeons (4% of maxillofacial surgeons),
f different grades according to the intensity of contamina-
ion of the geographic areas. All maxillofacial activity has
een highly reduced during the first month of COVID-19 epi-
emic: tumour surgery and trauma surgery has been widely
uaranteed, while other pathologies are accumulating delays.
It might be interesting and useful to compare the Italian
xperience with other countries, which are at present at a
ifferent time point of the outbreak.
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